Carregant...
Ticagrelor-induced thrombotic thrombocytopenic purpura: A case report and review of the literature
RATIONALE: Ticagrelor, a new type of P2Y(12) receptor antagonist, has been highly recommended to be used in acute coronary syndrome by the latest guideline, but its side effects are not well-known. We seek to illustrate a potential fatal condition, thrombotic thrombocytopenic purpura (TTP), caused b...
Guardat en:
| Publicat a: | Medicine (Baltimore) |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer Health
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6039671/ https://ncbi.nlm.nih.gov/pubmed/29952973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000011206 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|